• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-NHE1

NHE1 Monoclonal Antibody for WB, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, rat

Applications

WB, IHC, ELISA

Conjugaison

Non conjugué

Publications(7)

CloneNo.

3D9F3

N° de cat : 67363-1-Ig

Synonymes

SLC9A1, 3D9F3, APNH, APNH1, FLJ42224



Applications testées

Résultats positifs en WBcellules A549, cellules HEK-293, cellules HSC-T6, cellules Jurkat, cellules LNCaP, cellules NCI-H1299, cellules PC-12

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

67363-1-Ig cible NHE1 dans les applications de WB, IHC, ELISA et montre une réactivité avec des échantillons Humain, rat

Réactivité Humain, rat
Réactivité citéerat, Humain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène NHE1 Protéine recombinante Ag14329
Nom complet solute carrier family 9 (sodium/hydrogen exchanger), member 1
Masse moléculaire calculée 815 aa, 91 kDa
Poids moléculaire observé 110 kDa
Numéro d’acquisition GenBankBC012121
Symbole du gène NHE1
Identification du gène (NCBI) 6548
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

NHE1, also named as SLC9A1, is involved in pH regulation that can eliminate acids generated by active metabolism and counter adverse environmental conditions. NHE1 plays an important role in signal transduction. It has been shown that NHE1 participates in the development and progression of human breast cancer, gastric cancer and others. NHE1 has some isoforms with 91 kDa , 110 kDa (phosphoglycoprotein) and 210 kDa (dimeric protein). (PMID:28098891, 27751915, 8300588)

Protocole

Product Specific Protocols
WB protocol for NHE1 antibody 67363-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
ratWB

Acta Pharmacol Sin

Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling.

Authors - Ke Lin
  • KD Validated
humanIHC

Reproduction

An abnormal LPA/LPAR1-NHE1 axis leads to the autophagy deficiency of trophoblast cells in recurrent spontaneous abortion

Authors - Min Chen
humanWB

Cell Rep

Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC

Authors - Hui Lu
humanWB

Cell Rep

Mitochondrial transplantation rescues Ca2+ homeostasis imbalance and myocardial hypertrophy in SLC25A3-related hypertrophic cardiomyopathy

Authors - Shuang Li
humanWB

bioRxiv

Cystinosin is involved in Na+/H+ Exchanger 3 trafficking in the proximal tubular cells: new insights in the renal Fanconi syndrome in cystinosis

Authors - Veenita Khare
humanWB

Adv Sci (Weinh)

A Human Engineered Heart Tissue-Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin

Authors - Lin Cai
{{ptg:RelatedPrimaryAntibodies}}